Zhang YJ - Search Results

1

Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I_E /II_E extranodal natural killer/T-cell lymphoma.

Wang HY, Niu SQ, Yang YY, Li YY, Chen HB, Zhang YJ. Wang HY, et al. Among authors: zhang yj. Cancer Med. 2018 Dec;7(12):5863-5869. doi: 10.1002/cam4.1755. Epub 2018 Nov 28. Cancer Med. 2018. PMID: 30484966 Free PMC article. Clinical Trial.

2

[Clinical features and prognosis of nasal type NK/T cell lymphoma].

Zhang YJ, Hu WH, Liu H, Cheng EC, Ren ZM, Xia YF, Cui NJ. Zhang YJ, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):50-3. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16737622 Chinese.

3

[Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].

Zhang YJ, Ren ZM, Wu QL, He ZY, Huang Y, Xia YF, Lin TY, Cui NJ. Zhang YJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2006 Apr;27(4):217-21. Zhonghua Xue Ye Xue Za Zhi. 2006. PMID: 16875549 Chinese.

4

[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].

He YF, Zhang YJ, Li YH, Lin TY, Xia YF, Lu TX, Huang HQ, Jiang WQ, Xian CG, He YJ, Guan ZZ. He YF, et al. Among authors: zhang yj. Ai Zheng. 2006 Dec;25(12):1538-42. Ai Zheng. 2006. PMID: 17166382 Chinese.

5

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Zou GR, et al. Among authors: zhang yj. Ai Zheng. 2006 Dec;25(12):1543-9. Ai Zheng. 2006. PMID: 17166383 Chinese.

6

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.

Wang L, Xia ZJ, Huang HQ, Lu Y, Zhang YJ. Wang L, et al. Among authors: zhang yj. Int J Hematol. 2012 Nov;96(5):617-23. doi: 10.1007/s12185-012-1174-y. Epub 2012 Sep 16. Int J Hematol. 2012. PMID: 22983648 Clinical Trial.

7

Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up.

Wang L, Wang WD, Xia ZJ, Zhang YJ, Xiang J, Lu Y. Wang L, et al. Among authors: zhang yj. Med Oncol. 2014 Mar;31(3):860. doi: 10.1007/s12032-014-0860-4. Epub 2014 Jan 31. Med Oncol. 2014. PMID: 24481637

8

Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphoma.

Wang L, Wu-Xiao ZJ, Chen XQ, Zhang YJ, Lu Y, Xia ZJ. Wang L, et al. Among authors: zhang yj. Leuk Lymphoma. 2015 Apr;56(4):936-41. doi: 10.3109/10428194.2014.953146. Epub 2014 Oct 7. Leuk Lymphoma. 2015. PMID: 25110821

9

Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer/T cell lymphoma, nasal type.

Wang L, Xia ZJ, Lu Y, Zhang YJ. Wang L, et al. Among authors: zhang yj. Med Oncol. 2015 Jan;32(1):320. doi: 10.1007/s12032-014-0320-1. Epub 2014 Nov 28. Med Oncol. 2015. PMID: 25429828

10

A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.

Wang L, Xia ZJ, Lu Y, Wang QX, Niu SQ, Huang HQ, Zhang YJ. Wang L, et al. Among authors: zhang yj. Leuk Lymphoma. 2015;56(11):3038-44. doi: 10.3109/10428194.2015.1026817. Epub 2015 Mar 28. Leuk Lymphoma. 2015. PMID: 25747971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,672 results

Search Page

Filters